The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore

Human α1-antitrypsin (AAT) is an abundant acute phase glycoprotein expressing anti-protease and immunomodulatory activities, and is used as a biopharmaceutical to treat patients with inherited AAT deficiency. The pleiotropic properties of AAT provide a rationale for using this therapy outside of inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Tumpara, Srinu, Martinez-Delgado, Beatriz, Gomez-Mariano, Gema, Liu, Bin, DeLuca, David S., Korenbaum, Elena, Jonigk, Danny, Jugert, Frank, Wurm, Florian M., Wurm, Maria J., Welte, Tobias, Janciauskiene, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348051/
https://www.ncbi.nlm.nih.gov/pubmed/32719598
http://dx.doi.org/10.3389/fphar.2020.00983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348051/
https://www.ncbi.nlm.nih.gov/pubmed/32719598
http://dx.doi.org/10.3389/fphar.2020.00983

Ejemplares similares